CTLA4 and neoplasm: In syngeneic breast, pancreatic, and colorectal mouse tumor models, high-dose vitamin C potentiated the effects of anti-PD-1 and anti-CTLA-4 antibodies, which was mediated by the presence of functional T cells in the tumor microenvironment (Magrì et al, 2020).